Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Withdrawn 1Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 19Rectal Neoplasms 11Colorectal Neoplasms 11Colonic Neoplasms 11Central Nervous System Neoplasms 8Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 4Liver Neoplasms 4Kidney Neoplasms 4Carcinoma, Hepatocellular 4Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Lymphatic Metastasis 2Glioblastoma 2Breast Neoplasms, Male 2Astrocytoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1

Interventions

Tamoxifen 3Neoadjuvant Therapy 2Amplified Fragment Length Polymorphism Analysis 2Ultrasonography 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mammography 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Immunoenzyme Techniques 1Fulvestrant 1DNA Methylation 1Chemotherapy, Adjuvant 1Carboplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Intraductal, Noninfiltrating × Chemotherapy, Adjuvant × Clear all
NCT00077168 2009-02-09

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

National Cancer Institute (NCI)

Phase 2 Unknown
2,000 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡